Oxidative DNA damage induced by equine estrogen metabolites: Role of estrogen receptor α

Chemical Research in Toxicology

Volumn 15, Issue 4, 2002, Pages 512-519

  Liu, Xuemei ^a   Yao, Jiaqin ^a   Pisha, Emily ^a   Yang, Yanan ^a   Hua, Yousheng ^a   van Breemen, Richard B ^a   Bolton, Judy L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYEQUILENIN; 4,17BETA HYDROXYEQUILENIN; 8 HYDROXYDEOXYGUANOSINE; ALKALINE PHOSPHATASE; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; GLUTATHIONE; MALEIC ACID DIETHYL ESTER; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; CATALYSIS; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

BINDING, COMPETITIVE; BREAST NEOPLASMS; CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUILENIN; ESTRADIOL CONGENERS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EQUIDAE;

EID: 0036231082     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0101649     Document Type: Article

References (48)

1. Clinical management of women at increased risk for breast cancer
2. New role for estrogen in cancer?
3. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
4. Postmenopausal hormone therapy and mortality
5. Estrogen use and cancer incidence: A review
6. Role of quinoids in estrogen carcinogenesis
7. Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy
8. Breast cancer risk and duration of estrogen use - The role of study design in meta-analysis
9. Is estradiol a genotoxic mutagenic carcinogen?
10. Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: Relation to hormonal activity and cell proliferation
11. The role of oxidative stress in chemical carcinogenesis
12. The equine estrogen metabolite 4-hydroxyequilenin causes DNA single-strand breaks and oxidation of DNA bases in vitro
13. The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone
14. Bioreductive activation of catechol estrogen-ortho-quinones: Aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity
15. A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines
16. Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro
17. Oxyradicals and DNA damage
18. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: Correlation of DNA damage by free radicals with metabolic activation to quinones
19. Reactions with nitrosodisulfonate(III). Equilenin-quinone
20. Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells
21. Quantitative high-performance liquid chromatography analysis of DNA oxidized in vitro and in vivo
22. Comparison of negative and positive ion electrospray tandem mass spectrometry for the liquid chromatography tandem mass spectrometry analysis of oxidized deoxynucleosides
23. A simple technique for quantitation of low levels of DNA damage in individual cells
24. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the comet assay
25. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands
26. Hormone- and DNA-binding mechanisms of the recombinant human estrogen receptor
27. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms
28. Cell-based assay for the determination of estrogenic and anti-estrogenic activities
29. Dye exclusion tests for cell viability
30. Peroxynitrite-induced apoptosis in T84 and RAW 264.7 cells: Attenuation by L-ascorbic acid
31. Fluorescent microplate assay for respiratory burst of PMNs challenged in vitro with orthopedic metals
32. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues
33. 8-Hydroxyadenine (7,8-dihydro-8-oxoadenine) induces misincorporation in in vitro DNA synthesis and mutations in NIH 3T3 cells
34. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line)
35. Estrogen regulation of placental alkaline phosphatase gene expression in a human endometrial adenocarcinoma cell line
36. Apoptosis: Inhibitor or instigator of carcinogenesis?
37. Measurement of oxidative DNA damage by catechol estrogens and analogues in vitro
38. Formation, inhibition of formation, and repair of oxidative 8-hydroxyguanine DNA damage
39. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis
40. The etiology of breast cancer
41. Rapid screening of environmental chemicals for estrogen receptor binding capacity
42. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
43. ESR evidence for the generation of reactive oxygen species from the copper-mediated oxidation of the benzene metabolite, hydroquinone: Role in DNA damage
44. DNA damage resulting from the oxidation of hydroquinone by copper: Role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation
45. Detection of DNA damage in human lymphocytes by alkaline single cell gel electrophoresis after exposure to benzene or benzene metabolites
46. Toxicity of daunorubicin and naphthoquinones to HL-60 cells: An involvement of oxidative stress
47. Measurement of menadione-mediated DNA damage in human lymphocytes using the comet assay